Regulatory Information Management Article

Author:

Adam Sherlock

THE HARD WAY - the pharmaceutical industry has yet to make serious headway with efficient, formalised regulatory information management (Reg IM), according to a new survey.

Startling new research has found that just 20% of pharma companies have fully implemented a formal strategy for regulatory information management (Reg IM) - despite pressure from the authorities to abide by new rules governing data capture, tracking and submissions. The independent study, conducted for CSC by Landmark Solutions Exchange Survey in May this year, among senior regulatory information personnel, revealed a significant gulf between where organisations need to be and where they are today. Read more